NZ708574A - Anti-parasitic composition and method of treatment - Google Patents
Anti-parasitic composition and method of treatmentInfo
- Publication number
- NZ708574A NZ708574A NZ708574A NZ70857411A NZ708574A NZ 708574 A NZ708574 A NZ 708574A NZ 708574 A NZ708574 A NZ 708574A NZ 70857411 A NZ70857411 A NZ 70857411A NZ 708574 A NZ708574 A NZ 708574A
- Authority
- NZ
- New Zealand
- Prior art keywords
- composition
- treatment
- equivalent salt
- pharmaceutically equivalent
- parasitic composition
- Prior art date
Links
- 230000002141 anti-parasite Effects 0.000 title abstract 2
- 239000003096 antiparasitic agent Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 3
- 150000002596 lactones Chemical class 0.000 abstract 2
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 abstract 1
- 229960003997 doramectin Drugs 0.000 abstract 1
- 229960001614 levamisole Drugs 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Disclosed is a veterinary antiparasitic composition including a macrocyclic lactone (such as doramectin) or a pharmaceutically equivalent salt thereof, levamisole or a pharmaceutically equivalent salt thereof, and at least one antioxidant characterised in that the pH of the composition is in the range of 2.0 to 5.0, the macrocyclic lactone or a pharmaceutically equivalent salt thereof is solubilised within the composition, and wherein the composition includes more than 15 % w/v surfactant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ708574A NZ708574A (en) | 2011-06-23 | 2011-06-23 | Anti-parasitic composition and method of treatment |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ61881611 | 2011-06-23 | ||
| NZ708574A NZ708574A (en) | 2011-06-23 | 2011-06-23 | Anti-parasitic composition and method of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ708574A true NZ708574A (en) | 2023-02-24 |
Family
ID=85323562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ708574A NZ708574A (en) | 2011-06-23 | 2011-06-23 | Anti-parasitic composition and method of treatment |
Country Status (1)
| Country | Link |
|---|---|
| NZ (1) | NZ708574A (en) |
-
2011
- 2011-06-23 NZ NZ708574A patent/NZ708574A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015502797A1 (en) | THIENO[3,2-d]PYRIMIDINES DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS | |
| EA033311B1 (en) | Benzoxaborole derivatives as antibacterial agents | |
| WO2017083431A3 (en) | Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections | |
| MY173518A (en) | Antimicrobial compounds and methods of making and using the same | |
| CA2906880C (en) | Supplemented fish feed | |
| NZ719185A (en) | Crystalline forms of therapeutic compounds and uses thereof | |
| WO2011160024A3 (en) | Compounds useful as antiviral agents, compositions, and methods of use | |
| TN2015000090A1 (en) | Daptomycin formulations and uses thereof | |
| BR112016007368A2 (en) | method for regulating the ph of a soil, use of at least one alkaline earth carbonate-containing material, and use of an irrigation or spray system for the application of an aqueous suspension | |
| SG10201909412RA (en) | Composition for suppressing muscular fatty change | |
| MX355769B (en) | Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation. | |
| MX2015014310A (en) | Composition of macrocyclic lactones, levamisole, an amino sugar and an additional antiparasitic agent. | |
| TN2013000377A1 (en) | Thieno [2, 3-d] pyrimidine derivatives and their use to treat arrhythmia | |
| MX2016006927A (en) | Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis. | |
| NZ708574A (en) | Anti-parasitic composition and method of treatment | |
| MX2016011572A (en) | Organic acid antimicrobial compositions. | |
| WO2014167582A3 (en) | Vaccine composition for prophylaxis in ruminants | |
| WO2017064558A8 (en) | Novel immunostimulant | |
| WO2011031100A3 (en) | Aripiprazole-bentonite-aea hybrid, pharmaceutical composition containing the same and method for preparing the same | |
| MX2018007637A (en) | Injectable formulation of a macrocyclic lactone and levamisole. | |
| WO2009124723A3 (en) | Novel aureothin derivatives | |
| MY182136A (en) | Pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: ELANCO NEW ZEALAND SIMPSON GRIERSON, NZ Effective date: 20210707 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 9 YEARS UNTIL 29 JUN 2025 BY THOMSON REUTERS Effective date: 20230904 |